Physician profile
Mya E Levy
NPI 1205132628
$3,745.34
in general payments reported to CMS, 2019-2025
17 companies · $1,221 in 2025
The $1,221 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $746 · 2020: $236 · 2021: $1,266 · 2022: $213 · 2023: $25.89 · 2024: $36.52 · 2025: $1,221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $914 · Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $914.01 |
| Food and Beverage | $369.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,506.88 | 2021-2025 | Altaviva, Interstim |
| Coloplast Corp | $735.45 | 2019-2025 | |
| Axonics, INC. | $466.78 | 2021 | |
| Medtronic USA, INC. | $293.34 | 2019-2020 | |
| Boston Scientific Corporation | $178.45 | 2019-2021 | |
| Procept Biorobotics Corporation | $145.34 | 2021-2022 | |
| Neotract INC. | $123.52 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $64.67 | 2019-2020 | |
| Astellas Pharma US INC | $54.48 | 2019-2021 | |
| Allergan, INC. | $46.52 | 2021 | |
| Urogen Pharma, INC. | $25.49 | 2022 | |
| Sobi, INC | $19.87 | 2020 | |
| Sumitomo Pharma America, INC. | $19.19 | 2024 | Gemtesa |
| Olympus America INC. | $18.56 | 2020 | |
| Abbvie INC. | $17.33 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Metuchen Pharmaceuticals | $16.91 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $12.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mya Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.